Table 5.

Laser treatment response according to age, gender, type of fungi, clinical type of onychomycosis, and location.

Patients	Excellent response (>75%)	Very good response (50–74)	Good response (25–49)	Moderate response (10–24%)	Low response (>9%)	No response (0%)
Gender
Female	10 (10.6%)	44 (46.8%)	25 (26.6%)	10 (10.6%)	0 (0.0%)	5 (5.3%)
Male	2 (5.4%)	9 (24.3%)	16 (43.2%)	9 (24.3%)	0 (0.0%)	1 (2.7%)
Age
<30 y.o	3 (15.0%)	4 (20.0%)	10 (50.0%)	2 (10.0%)	0 (0.0%)	1 (5.0%)
30–60	9 (10.5%)	37 (43.0%)	24 (27.9%)	13 (15.1%)	0 (0.0%)	3 (3.5%)
>60	0 (0.0%)	12 (50.0%)	6 (25.0%)	4 (16.7%)	0 (0.0%)	2 (8.3%)
Onychomycosis severity
Mild	3 (50.0%)	2 (33.3%)	1 (16.7%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Moderate	5 (13.5%)	23 (62.2%)	9 (24.3%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Severe	4 (4.5%)	28 (31.8%)	31 (35.2%)	19 (21.6%)	0 (0.0%)	6 (6.8%)
Types of fungi
T. rubrum	10 (9.3%)	51 (47.2%)	38 (35.2%)	8 (7.4%)	0 (0.0%)	1 (0.9%)
Candida	1 (5.3%)	1 (5.3%)	3 (15.8%)	10 (52.6%)	0 (0.0%)	4 (21.1%)
Non dermatophytes	1 (25.0%)	1 (25.0%)	0 (0.0%)	1	0 (0.0%)	1 (25.0%)
T. mentographytes	9 (9.4%)	48 (50.0%)	35 (36.5%)	4 (4.2%)	0 (0.0%)	0 (0.0%)
Clinical type of onychomycosis
Distal subungual	9 (7.3%)	50 (40.7%)	40 (32.5%)	18 (14.6%)	0 (0.0%)	6 (4.9%)
Proximal  subungual	0 (0.0%)	1 (100.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Superficial white	1 (50.0%)	0 (0.0%)	0 (0.0%)	1 (50.0%)	0 (0.0%)	0 (0.0%)
Dystrophic	2 (4.3%)	14 (29.8%)	17 (36.2%)	11 (23.4%)	0 (0.0%)	3 (6.4%)
Lateral edge	2 (4.3%)	5 (38.5%)	5 (38.5%)	0 (0.0%)	0 (0.0%)	1 (7.7%)
Location
Hand	0 (0.0%)	1 (9.1%)	3 (27.3%)	6 (54.5%)	0 (0.0%)	1 (9.1%)
Feet	9 (9.9%)	38 (41.8%)	27 (29.7%)	14 (15.4%)	0 (0.0%)	3 (3.3%)